Molecular Biology of Tumors

Data

Official data in SubjectManager for the following academic year: 2023-2024

Course director

Number of hours/semester

lectures: 28 hours

practices: 0 hours

seminars: 0 hours

total of: 28 hours

Subject data

  • Code of subject: OPF-TMB-T
  • 2 kredit
  • Pharmacy
  • Optional modul
  • autumn
Prerequisites:

OPO-GL1-T completed , OPO-G2B-T completed

Course headcount limitations

min. 4 – max. 24

Available as Campus course for 20 fő számára. Campus-karok: ÁOK ETK GYTK TTK

Topic

During the course we will discuss the molecular mechanisms of tumor development. We will deal with characteristic features of tumor cells, and cancers. The function of influencing factors, risk factors, causes, the underlying molecular mechanisms, e.g. mutations, the role of oncogenes and tumor-suppressor genes, DNA repair, epigenetics and the role of immune system will be discussed in detail. We will emphasize the function of cell signaling pathways and the failure of apoptosis in tumorigenesis. We will speak about the molecular mechanisms of invasion and metastasis of tumors, the genes and proteins which have a crucial role in these processes. The participants will get an insight into the molecular diagnosis, genetic aberrations, and molecular alterations of human cancers. We will discuss the possibilities for cancer therapies, the new approaches such as gene therapy and immunotherapy.

Lectures

  • 1. Introduction to cancers: classification and characterization of cancers, causes of cancer, properties of cancer cells, principles of therapies, targets of therapies - Dr. Pandur Edina
  • 2. Introduction to cancers: classification and characterization of cancers, causes of cancer, properties of cancer cells, principles of therapies, targets of therapies - Dr. Pandur Edina
  • 3. Tumor genetics: mutations, carcinogenic agents, inheritance, tumor genes, defects in DNA repair and predispositions to cancer, cell protection mechanisms - Dr. Pandur Edina
  • 4. Tumor genetics: mutations, carcinogenic agents, inheritance, tumor genes, defects in DNA repair and predispositions to cancer, cell protection mechanisms - Dr. Pandur Edina
  • 5. Tumor epigenetics: mechanisms of epigenetic inheritance, imprinting, DNA methylation, epigenetics of cell differentiation and tissue homeostasis - Jánosa Gergely
  • 6. Tumor epigenetics: mechanisms of epigenetic inheritance, imprinting, DNA methylation, epigenetics of cell differentiation and tissue homeostasis - Jánosa Gergely
  • 7. Oncogenes and tumor-suppressor genes - Dr. Pandur Edina
  • 8. Oncogenes and tumor-suppressor genes - Dr. Pandur Edina
  • 9. The cell cycle, apoptosis and senescence: checkpoints, therapeutic targets and inhibitors, molecular mechanisms of apoptosis, replicative senescence and its disturbances in human cancers - Pap Ramóna
  • 10. The cell cycle, apoptosis and senescence: checkpoints, therapeutic targets and inhibitors, molecular mechanisms of apoptosis, replicative senescence and its disturbances in human cancers - Pap Ramóna
  • 11. Signaling pathways in tumors: MAPK, PI3K, TP53 network, NFkappaB, TGFbeta, STAT signaling - Dr. Pandur Edina
  • 12. Signaling pathways in tumors: MAPK, PI3K, TP53 network, NFkappaB, TGFbeta, STAT signaling - Dr. Pandur Edina
  • 13. Invasion and metastasis: genes and proteins involved in cell-to-cell, cell-matrix adhesion, in extracellular matrix remodeling during tumor invasion; angiogenesis. - Dr. Pandur Edina
  • 14. Invasion and metastasis: genes and proteins involved in cell-to-cell, cell-matrix adhesion, in extracellular matrix remodeling during tumor invasion; angiogenesis. - Dr. Pandur Edina
  • 15. The role of immune system in tumors: inflammation, infections, cancer vaccines, inhibition of the immune system - Pap Ramóna
  • 16. The role of immune system in tumors: inflammation, infections, cancer vaccines, inhibition of the immune system - Pap Ramóna
  • 17. Stem cells and cancer: Wnt signaling, Hh signaling, differentiation therapy - Dr. Pandur Edina
  • 18. Stem cells and cancer: Wnt signaling, Hh signaling, differentiation therapy - Dr. Pandur Edina
  • 19. Cancer prevention: nutrients, energy metabolism of tumors, hormones and gene interactions - Pap Ramóna
  • 20. Cancer prevention: nutrients, energy metabolism of tumors, hormones and gene interactions - Pap Ramóna
  • 21. Diagnosis of tumors: molecular diagnosis, molecular detection and classification - Jánosa Gergely
  • 22. Diagnosis of tumors: molecular diagnosis, molecular detection and classification - Jánosa Gergely
  • 23. Human cancers I: common properties, genetic aberrations, molecular alterations, histology and etiology of cancers - Dr. Tóth Dénes
  • 24. Human cancers I: common properties, genetic aberrations, molecular alterations, histology and etiology of cancers - Dr. Tóth Dénes
  • 25. Human cancers II: common properties, genetic aberrations, molecular alterations, histology and etiology of cancers - Dr. Tóth Dénes
  • 26. Human cancers II: common properties, genetic aberrations, molecular alterations, histology and etiology of cancers - Dr. Tóth Dénes
  • 27. Drugs in cancer therapy: molecular mechanisms of cancer chemotherapy, targeted drug therapy, immunotherapy, gene therapy - Dr. Pandur Edina
  • 28. Drugs in cancer therapy: molecular mechanisms of cancer chemotherapy, targeted drug therapy, immunotherapy, gene therapy - Dr. Pandur Edina

Practices

Seminars

Reading material

Obligatory literature

Literature developed by the Department

Educational materials will be uploaded to Neptun MeetStreet.

Notes

Recommended literature

Lauren Pecorino: Molecular Biology of Cancer
Wolfgang Arthur Schulz: Molecular Biology of Human Cancers

Conditions for acceptance of the semester

Max. 3 absences

Mid-term exams

One assay, one midterm exam.

Making up for missed classes

Personal consultation

Exam topics/questions

Simple choice test based on the lectures.

Examiners

Instructor / tutor of practices and seminars